Brief: Labomar Signs New Commercial Agreement With Bayer
29/01/2021 13:39
Jan 29 (Reuters) - Labomar SpA LBM.MI :
* NEW COMMERCIAL AGREEMENT WITH BAYER
* IN DETAIL, LABOMAR TO DEVELOP AND PRODUCE REFERENCES IN
DIFFERENT PHARMACEUTICAL FLAVORS AND FORMS, WHILE BAYER WILL
HANDLE DISTRIBUTION
Source text: bit.ly/2MyqoD6
Further company coverage: LBM.MI
(Gdansk newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Labomar SpA
See all newsBrief: Takeup In Takeover Bid By LBM Next For Labomar Reaches 47.009% Of Residual Shares In Last Day Of Sell Out Period
Brief: First Capital Sells 4.9% Stake In Labomar For More Than EUR 9.0 Mln to LBM Next
Brief: Labomar Shareholder LBM Holding Transfers Its 94.1% Stake In Labomar Share Capital To LBM Next
Brief: Labomar Shareholder Master Lab Sa Dropped Below 5% Treshold In Labomar Share Capital
Brief: Lbm Next To Own 94.096% Of Labomar Share Capital At End Of Adhesion Period Of Takeover Bid